SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.836
EU - Europa 1.909
AS - Asia 1.326
SA - Sud America 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 10.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.831
CN - Cina 833
UA - Ucraina 578
GB - Regno Unito 336
TR - Turchia 307
DE - Germania 268
IT - Italia 205
SG - Singapore 143
SE - Svezia 139
PL - Polonia 133
FI - Finlandia 116
FR - Francia 33
BE - Belgio 32
AT - Austria 28
IR - Iran 14
RU - Federazione Russa 10
NL - Olanda 8
IN - India 7
KR - Corea 7
BR - Brasile 6
CZ - Repubblica Ceca 6
CA - Canada 5
ES - Italia 4
NZ - Nuova Zelanda 4
RO - Romania 4
VN - Vietnam 4
EU - Europa 3
HK - Hong Kong 3
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
ID - Indonesia 2
LI - Liechtenstein 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CH - Svizzera 1
EG - Egitto 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 10.091
Salva come PNG Salva come JPEG
Città #
Woodbridge 891
Fairfield 841
Jacksonville 619
Houston 590
Chandler 504
Ann Arbor 458
Ashburn 407
Wilmington 331
Seattle 328
Cambridge 282
Nanjing 194
Beijing 193
Izmir 188
New York 142
Princeton 134
Warsaw 133
San Diego 87
Singapore 82
Boardman 60
Shenyang 58
Shanghai 54
Milan 52
Nanchang 47
Hebei 38
Tianjin 38
Jiaxing 37
Los Angeles 35
San Mateo 34
Brussels 32
Ferrara 32
Vienna 28
Changsha 26
Jinan 23
Ningbo 23
Norwalk 20
Falls Church 19
Washington 18
Mountain View 17
Philadelphia 16
Dearborn 15
Kunming 15
Leawood 15
Auburn Hills 14
Augusta 14
Orange 12
Guangzhou 11
Redwood City 11
Taizhou 11
Zhengzhou 11
Ardabil 10
London 10
Verona 10
Monmouth Junction 8
Des Moines 7
Indiana 7
Bologna 6
Bremen 6
Hangzhou 6
Addison 5
Brno 5
Haikou 5
Helsinki 5
Lanzhou 5
Changchun 4
Rome 4
Acton 3
Amsterdam 3
Auckland 3
Bari 3
Chicago 3
Dong Ket 3
Napoli 3
Novosibirsk 3
Paris 3
Pieve Emanuele 3
Wandsworth 3
Düsseldorf 2
Genoa 2
Hong Kong 2
Hounslow 2
Jakarta 2
Madrid 2
Munich 2
North Bergen 2
Pearland 2
Pune 2
Roseto Degli Abruzzi 2
Sofia 2
São Paulo 2
Taiyuan 2
Tappahannock 2
Toronto 2
Turin 2
Valeggio sul Mincio 2
Vanzago 2
Alcalá De Henares 1
Allahabad 1
Andover 1
Angus 1
Aprilia 1
Totale 7.419
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 190
null 179
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 152
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 137
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 135
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 125
Herpes Simplex Virus Growth, Preparation, and Assay 125
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 124
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 122
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 121
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 121
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 121
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 120
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 117
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 116
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 114
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 113
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 112
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 111
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 111
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 111
HSV as a vector in vaccine development and gene therapy 110
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 110
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 110
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 109
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 107
Replication-competent herpes simplex vectors: design and applications 107
null 107
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 106
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 106
null 104
Herpesvirus/retrovirus chimeric vectors 104
null 104
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 104
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 103
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 102
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 101
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 100
Purinergic Signaling: A New Pharmacological Target Against Viruses? 100
null 99
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 99
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 98
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 98
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 97
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 97
MEMBRANE PROTEIN PATTERN IN HEREDITARY SPHEROCYTOSIS IN FIVE SUBJECTS FROM NORTH-EAST ITALY OBTAINED BY SDS-PAGE USING N,N'-DIALLYLTARTARDIAMIDE 97
HSV as a vector in vaccine development and gene therapy 97
null 95
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 94
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 93
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 93
State of viral DNA in BK virus-transformed rabbit cells 92
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 91
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 91
null 89
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 88
null 88
null 88
HSV-1 virions engineered for specific binding to cell surface receptors 85
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 84
Virus erpetici come vettori vaccinali 84
null 83
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 83
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 82
Capitolo 55 Retrovirus 82
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 81
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 81
null 81
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 80
null 80
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 79
Molecular diagnosis of herpes simplex encephalitis 74
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 71
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 71
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 70
CELL-TYPE DEPENDENT SENSITIVITY OF HERPES-SIMPLEX-VIRUS-1 MUTANTS TO PLAQUE DEVELOPMENT INHIBITION BY AN ANTI-GD MONOCLONAL-ANTIBODY 69
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 68
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 67
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 64
Niosomes containing HSV immunogens as possible vaccine against genital herpes 63
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 62
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 61
Transformation by defined regions of herpes simplex virus DNA. 61
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 61
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 61
Capitolo 44 Herpesviridae 60
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 60
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 59
Intranasal immunization with non-ionic surfactant vescicles containing a secreted recombinant form of gB protein confers protective immunity against genital herpes in mice 58
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 58
Ocular disease patterns caused by genetically related mutants of Herpes simplex virus type 1. 58
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 57
Niosomes for vaginal administration of an antiherpetic peptide 56
Gene therapy of the nervous system by herpes virus vectors 56
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 55
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 55
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors 54
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 54
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 54
Virus vectors for immunoprophylaxis 53
Totale 9.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.564
Totale 43.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.900 0 79 94 327 142 232 180 244 148 238 176 40
2020/20211.461 136 124 69 152 66 173 65 175 24 175 227 75
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/2025106 59 47 0 0 0 0 0 0 0 0 0 0
Totale 10.185